内皮唾液酸蛋白在人增生性瘢痕中的表达及其对成纤维细胞表型的调控

张清怡; 张丽霞; 韩东晖; 焦晓春; 郑朝; 郭凯; 杨云舒

doi:10.3760/cma.j.cn501225-20231030-00154

内皮唾液酸蛋白在人增生性瘢痕中的表达及其对成纤维细胞表型的调控

doi: 10.3760/cma.j.cn501225-20231030-00154

张清怡^{1, 2},
张丽霞¹,
韩东晖³,
焦晓春¹,
郑朝¹,
郭凯¹,
杨云舒^1, ,

1.
空军军医大学第一附属医院全军烧伤中心，烧伤与皮肤外科，西安　　710032
2.
空军军医大学基础医学院学员三大队，西安　　710032
3.
空军军医大学第一附属医院泌尿外科，西安　　710032

基金项目:

国家自然科学基金青年科学基金项目 81501666, 82302809

陕西省重点研发计划 2022SF-399

详细信息

通讯作者:
杨云舒，Email：yangys0815@qq.com

计量
- 文章访问数: 92
- HTML全文浏览量: 18
- PDF下载量: 11
- 被引次数: 0
出版历程
- 收稿日期: 2023-10-30

Expression of endosialin in human hypertrophic scars and its regulation on fibroblast phenotype

1.
Department of Burns and Cutaneous Surgery, Burn Center of PLA, the First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China
2.
The Third Student Battalion, School of Basic Medical Sciences of Air Force Medical University, Xi'an 710032, China
3.
Department of Urology, the First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China

Funds:

Youth Science Foundation Program of National Natural Science Foundation of China 81501666, 82302809

Shaanxi Provincial Key Research and Development Plan 2022SF-399

More Information

Corresponding author: Yang Yunshu, Email: yangys0815@qq.com

摘要

摘要: 目的探讨内皮唾液酸蛋白即CD248在人增生性瘢痕（HS）中的表达及其对人HS成纤维细胞（HSF）表型的调控作用。方法采用实验研究方法。2023年3—5月，空军军医大学第一附属医院烧伤与皮肤外科收治3例HS患儿，其中女2例、男1例，年龄1岁10个月~2岁。取前述患儿术中切除的HS组织及行全厚皮移植术后剩余的全厚皮片即正常皮肤组织，进行后续实验。取前述2种组织，行苏木精-伊红染色后观察组织结构，行Masson染色后观察组织中胶原分布情况，行免疫组织化学染色后观测组织中CD248表达情况。取HS组织，采用组织块培养法提取原代HSF，取第3~5代HSF进行后续实验。将HSF按随机数字表法分为免疫球蛋白G78（IgG78）处理组与IgG对照组，分别用终物质的量浓度为200 nmol/L的人源性CD248单克隆抗体IgG78与人源性IgG对照抗体处理24 h，采用实时荧光定量反转录PCR法检测细胞中Ⅰ型胶原蛋白和α平滑肌肌动蛋白（α-SMA）的mRNA表达，采用蛋白质印迹法检测细胞中Ⅰ型胶原蛋白和α-SMA的蛋白表达，采用免疫荧光法检测细胞中Ⅰ型胶原蛋白和α-SMA的定位和蛋白表达情况。各实验样本数均为3。对数据行配对样本 t检验和独立样本 t检验。结果相较于正常皮肤组织，HS组织中表皮与真皮层均明显增厚，真皮层中胶原大量蓄积且排布紊乱。HS组织中CD248表达量明显高于正常皮肤组织（ t=5.29， P<0.05）。处理24 h，IgG78处理组HSF中Ⅰ型胶原蛋白、α-SMA的mRNA表达量分别为0.39±0.05、0.56±0.09，分别明显低于IgG对照组的1.00±0.07、1.00±0.08（ t值分别为11.87、6.49， P值均<0.05）；IgG78处理组HSF中Ⅰ型胶原蛋白、α-SMA的蛋白表达量分别为0.617±0.011、0.67±0.14，分别明显低于IgG对照组的1.259±0.052、1.23±0.16（ t值分别为20.92、4.52， P值均<0.05）。处理24 h，免疫荧光染色显示，Ⅰ型胶原蛋白、α-SMA主要定位在2组HSF的细胞质中，IgG78处理组HSF中Ⅰ型胶原蛋白、α-SMA的蛋白表达均较IgG对照组明显减少。结论 CD248在人HS中表达显著增高，靶向阻断CD248能够显著抑制人HSF的胶原合成与向肌Fb的转分化。
- 瘢痕 /
- 成纤维细胞 /
- 细胞外基质 /
- 细胞转分化 /
- 内皮唾液酸蛋白 /
- 胶原合成
Abstract: Objective To explore the expression of endosialin, i.e., CD248 in human hypertrophic scars (HSs) and its regulatory effect on the phenotype of hypertrophic scar fibroblasts (HSFs). Methods The method of experimental research was used. From March to May, 2023, 3 pediatric patients with HS were admitted to the Department of Burns and Cutaneous Surgery of the First Affiliated Hospital of Air Force Medical University, including 2 females and 1 male, aged one year ten months to two years. The HS tissue resected during the surgery and the remaining full-thickness skin graft, i.e., normal skin tissue after full-thickness skin grafting were collected from the aforementioned pediatric patients for subsequent experiments. Using the aforementioned two types of tissue, the histological structures were observed by hematoxylin-eosin staining, collagen distribution was observed by Masson staining, and the expression of CD248 was observed and measured by immunohistochemical staining. The primary HSFs were isolated from HS tissue using explant culture technique, and the 3 ^rd to 5 ^th passages of HSFs were used in subsequent experiments. According to the random number table, HSFs were divided into immunoglobulin G78 (IgG78)-treated group and IgG control group, which were treated with 200 nmol/L human CD248 monoclonal antibody IgG78 and human IgG control antibody for 24 h, respectively. The mRNA expressions of collagen type Ⅰ (Col Ⅰ) and α-smooth muscle actin (α-SMA) in HSFs were measured by real-time fluorescence quantitative reverse transcription polymerase chain reaction, the protein expressions of Col Ⅰ and α-SMA in HSFs were detected by Western blotting, and the intracellular location and protein expressions of Col Ⅰ and α-SMA were detected by immunofluorescence method. The number of samples in each experiment was 3. Data were statistically analyzed with paired sample t test and independent sample t test. Results Compared with those in normal skin tissue, the epidermis and dermis in HS tissue were significantly thicker, with massive accumulation and disordered arrangement of collagen in the dermis. The expression of CD248 in HS tissue was significantly upregulated compared with that in normal skin tissue ( t=5.29, P<0.05). At post treatment hour 24, the mRNA expressions of Col Ⅰ and α-SMA of HSFs in IgG78-treated group were 0.39±0.05 and 0.56±0.09, respectively, which were significantly lower than 1.00±0.07 and 1.00±0.08 in IgG control group, respectively (with t values of 11.87 and 6.49, respectively, P values all <0.05). The protein expressions of Col Ⅰ and α-SMA of HSFs in IgG78-treated group were 0.617±0.011 and 0.67±0.14, respectively, which were significantly lower than 1.259±0.052 and 1.23±0.16 in IgG control group, respectively (with t values of 20.92 and 4.52, respectively, P values all <0.05). At post treatment hour 24, immunofluorescence staining showed that Col Ⅰ and α-SMA mainly located in the cytoplasm of HSFs in the two groups, and the protein expressions of Col Ⅰ and α-SMA of HSFs in IgG78-treated group were obviously downregulated compared with those in IgG control group. Conclusions The expression of CD248 is significantly upregulated in human HS. Targeted blockade of CD248 can significantly inhibit the collagen synthesis by HSFs and the transdifferentiation of HSFs into myofibroblasts.
- Cicatrix /
- Fibroblasts /
- Extracellular matrix /
- Cell transdifferentiation /
- Endosialin /
- Collagen synthesis
张清怡：实施研究、起草文章；张丽霞：实施研究、对文章的知识性内容作批判性评审；韩东晖：实施研究、分析并解释数据；焦晓春：采集数据、统计分析；郑朝、郭凯、杨云舒：支持性贡献、研究指导

所有作者均声明不存在利益冲突

HTML全文

下载: 全尺寸图片幻灯片

1 人增生性瘢痕（HS）组织与正常皮肤组织结构和胶原分布及CD248的表达情况。1A、1D.分别为正常皮肤组织和HS组织结构情况，图1D的表皮与真皮层均较图1A增厚苏木精-伊红×15；1B、1E.分别为正常皮肤组织和HS组织中胶原情况，图1E中胶原（蓝色）排列相较图1B紊乱且较为致密 Masson×15；1C、1F.分别为正常皮肤组织和HS组织中CD248表达情况，图1F中CD248（阳性染色为黄色/棕色）表达量显著高于图1C 二氨基联苯胺×15

注：CD248即为内皮唾液酸蛋白

下载: 全尺寸图片幻灯片

2 蛋白质印迹法检测的2组人增生性瘢痕来源成纤维细胞处理24 h后Ⅰ型胶原蛋白和α-SMA的蛋白表达

注：α-SMA为α平滑肌肌动蛋白；1、2分别指示IgG对照组、IgG78处理组；IgG为免疫球蛋白G，IgG78为人源性内皮唾液酸蛋白即CD248单克隆抗体

下载: 全尺寸图片幻灯片

3 2组人增生性瘢痕来源成纤维细胞处理24 h后Ⅰ型胶原蛋白和α-SMA定位与蛋白表达 Alexa Fluor 488-Alexa Fluor 594-4',6-二脒基-2-苯基吲哚×60。3A、3B、3C.分别为IgG对照组细胞核染色、Ⅰ型胶原蛋白染色、细胞核与Ⅰ型胶原蛋白染色重叠图片，细胞核完整，Ⅰ型胶原蛋白的蛋白表达较多且主要定位在细胞质中；3D、3E、3F.分别为IgG78处理组细胞核染色、Ⅰ型胶原蛋白染色、细胞核与Ⅰ型胶原蛋白染色重叠图片，细胞核完整，图3E细胞质中Ⅰ型胶原蛋白的蛋白表达较图3B明显减少；3G、3H、3I.分别为IgG对照组细胞核染色、α-SMA染色、细胞核与α-SMA染色重叠图片，细胞核完整，α-SMA蛋白表达较多且主要定位在细胞质中；3J、3K、3L.分别为IgG78处理组细胞核染色、α-SMA染色、细胞核与α-SMA染色重叠图片，细胞核完整，图3K细胞质中α-SMA蛋白表达较图3H明显减少

注：α-SMA为α平滑肌肌动蛋白，IgG为免疫球蛋白G，IgG78为人源性内皮唾液酸蛋白即CD248单克隆抗体；细胞核阳性染色为蓝色，Ⅰ型胶原蛋白阳性染色为绿色，α-SMA阳性染色为红色

下载: 全尺寸图片幻灯片

表1 2组人增生性瘢痕来源成纤维细胞处理24 h后Ⅰ型胶原蛋白和α-SMA的mRNA与蛋白表达比较（ x ¯ ± s ）

表1. Comparison of the mRNA and protein expres‑sions of collagen Ⅰ and α-SMA of two groups of human hypertrophic scar-derived fibro‑blasts after 24 h of treatment

组别	样本量	Ⅰ型胶原蛋白		α-SMA
组别	样本量	mRNA	蛋白	mRNA	蛋白
IgG78处理组	3	0.39±0.05	0.617±0.011	0.56±0.09	0.67±0.14
IgG对照组	3	1.00±0.07	1.259±0.052	1.00±0.08	1.23±0.16
t值		11.87	20.92	6.49	4.52
P值		<0.001	<0.001	0.003	0.011
注：α-SMA为α平滑肌肌动蛋白，IgG为免疫球蛋白G，IgG78为人源性内皮唾液酸蛋白即CD248单克隆抗体

下载: 导出CSV

参考文献(31)

[1]	史亮亮,刘名倬,江政英,等.药物干预增生性瘢痕的研究进展[J].中华烧伤与创面修复杂志,2022,38(12):1179-1184.DOI: 10.3760/cma.j.cn501120-20211118-00388.
[2]	FinnertyCC,JeschkeMG,BranskiLK,et al.Hypertrophic scarring: the greatest unmet challenge after burn injury[J].Lancet,2016,388(10052):1427-1436.DOI: 10.1016/S0140-6736(16)31406-4.
[3]	KarppinenSM,HeljasvaaraR,GullbergD,et al.Toward understanding scarless skin wound healing and pathological scarring[J].F1000Res,2019,8:F1000 Faculty Rev-787.DOI: 10.12688/f1000research.18293.1.
[4]	FinlayV,BurrowsS,KendellR,et al.Modified Vancouver Scar Scale score is linked with quality of life after burn[J].Burns,2017,43(4):741-746.DOI: 10.1016/j.burns.2016.11.007.
[5]	OgawaR.The most current algorithms for the treatment and prevention of hypertrophic scars and keloids: a 2020 update of the algorithms published 10 years ago[J].Plast Reconstr Surg,2022,149(1):79e-94e.DOI: 10.1097/PRS.0000000000008667.
[6]	SchulzJN,PlomannM,SengleG,et al.New developments on skin fibrosis-essential signals emanating from the extracellular matrix for the control of myofibroblasts[J].Matrix Biol,2018,68-69:522-532.DOI: 10.1016/j.matbio.2018.01.025.
[7]	WalravenM,HinzB.Therapeutic approaches to control tissue repair and fibrosis: extracellular matrix as a game changer[J].Matrix Biol,2018,71-72:205-224.DOI: 10.1016/j.matbio.2018.02.020.
[8]	ŢuţuianuR,RoşcaAM,FloreaG,et al.Heterogeneity of human fibroblasts isolated from hypertrophic scar[J].Rom J Morphol Embryol,2019,60(3):793-802.
[9]	RodriguesM,KosaricN,BonhamCA,et al.Wound healing: a cellular perspective[J].Physiol Rev,2019,99(1):665-706.DOI: 10.1152/physrev.00067.2017.
[10]	ShirakamiE,YamakawaS,HayashidaK.Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence[J/OL].Burns Trauma,2020,8:tkz003[2023-10-30].https://pubmed.ncbi.nlm.nih.gov/32341924/.DOI: 10.1093/burnst/tkz003.
[11]	KhanKA,NaylorAJ,KhanA,et al.Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface[J].Oncogene,2017,36(44):6097-6108.DOI: 10.1038/onc.2017.214.
[12]	ValdezY,MaiaM,ConwayEM.CD248: reviewing its role in health and disease[J].Curr Drug Targets,2012,13(3):432-439.DOI: 10.2174/138945012799424615.
[13]	Di BenedettoP,RuscittiP,LiakouliV,et al.Linking myofibroblast generation and microvascular alteration: the role of CD248 from pathogenesis to therapeutic target (review)[J].Mol Med Rep,2019,20(2):1488-1498.DOI: 10.3892/mmr.2019.10429.
[14]	ChristianS,AhornH,KoehlerA,et al.Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium[J].J Biol Chem,2001,276(10):7408-7414.DOI: 10.1074/jbc.M009604200.
[15]	LiuS,HanD,XuC,et al.Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts[J].Mol Med,2022,28(1):37.DOI: 10.1186/s10020-022-00460-1.
[16]	XuC,LiuS,YangF,et al.Antibody-drug conjugates targeting CD248+ myofibroblasts effectively alleviate renal fibrosis in mice[J].FASEB J,2022,36(2):e22102.DOI: 10.1096/fj.202101441R.
[17]	ZhangJ,LiY,BaiX,et al.Recent advances in hypertrophic scar[J].Histol Histopathol,2018,33(1):27-39.DOI: 10.14670/HH-11-908.
[18]	MarzecM,Kandefer-GolaM,JanusI,et al.Endosialin (CD248) expression in fibromas and soft-tissue fibrosarcomas in dogs[J].In Vivo,2021,35(3):1467-1472.DOI: 10.21873/invivo.12399.
[19]	XuC,ZhangK,YangF,et al.CD248+ cancer-associated fibroblasts: a novel prognostic and therapeutic target for renal cell carcinoma[J].Front Oncol,2021,11:773063.DOI: 10.3389/fonc.2021.773063.
[20]	PaiCH,LinSR,LiuCH,et al.Targeting fibroblast CD248 attenuates CCL17-expressing macrophages and tissue fibrosis[J].Sci Rep,2020,10(1):16772.DOI: 10.1038/s41598-020-73194-x.
[21]	MatsushimaS,AoshimaY,AkamatsuT,et al.CD248 and integrin alpha-8 are candidate markers for differentiating lung fibroblast subtypes[J].BMC Pulm Med,2020,20(1):21.DOI: 10.1186/s12890-020-1054-9.
[22]	CiprianiP,RuscittiP,Di ColaI,et al.Fibroblast expression of CD248 may contribute to exacerbation of microvascular damage during systemic sclerosis[J].Rheumatology (Oxford),2023,62(3):1317-1325.DOI: 10.1093/rheumatology/keac377.
[23]	Di BenedettoP,LiakouliV,RuscittiP,et al.Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy[J]. Arthritis Res Ther,2018,20(1):223.DOI: 10.1186/s13075-018-1719-4.
[24]	BartisD,CrowleyLE,D'SouzaVK,et al.Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis[J].BMC Pulm Med,2016,16(1):51.DOI: 10.1186/s12890-016-0211-7.
[25]	WilhelmA,AldridgeV,HaldarD,et al.CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism[J].Gut,2016,65(7):1175-1185.DOI: 10.1136/gutjnl-2014-308325.
[26]	KuoCH,WuYF,ChangBI,et al.Interference in melanoma CD248 function reduces vascular mimicry and metastasis[J].J Biomed Sci,2022,29(1):98.DOI: 10.1186/s12929-022-00882-3.
[27]	WuJ,LiuX,WuJ,et al.CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression[J].Biochim Biophys Acta Mol Basis Dis,2022,1868(11):166521.DOI: 10.1016/j.bbadis.2022.166521.
[28]	MoglerC,WielandM,KönigC,et al.Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage[J].EMBO Mol Med,2015,7(3):332-338.DOI: 10.15252/emmm.201404246.
[29]	ArmulikA,GenovéG,BetsholtzC.Pericytes: developmental, physiological, and pathological perspectives, problems, and promises[J].Dev Cell,2011,21(2):193-215.DOI: 10.1016/j.devcel.2011.07.001.
[30]	WangZ,SongQ,LiH.Suppressive effects of human fetal keratinocytes on the proliferation, differentiation and extracellular matrix synthesis of human hypertrophic scar fibroblasts in vitro[J].Mol Med Rep,2017,16(4):5377-5385.DOI: 10.3892/mmr.2017.7220.
[31]	周祥,杨发,韩东晖,等.CD248抗体IgG78抑制HFL-1人胚肺成纤维细胞的增殖、迁移[J].细胞与分子免疫学杂志,2021,37(4):289-294.